First version of the Union list of critical medicines agreed to help avoid potential shortages in the EU

12 December 2023 - The European Commission, the Heads of Medicines Agencies and EMA have published the first version of the ...

Read more →

Novo Nordisk to discontinue Levemir insulin in US market

8 November 2023 - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, ...

Read more →

Hormone replacement therapy patch shortages are having a big impact on the women who need them

4 November 2023 - Women are being thrust back into the most severe stages of menopause amid long-running national shortages of ...

Read more →

Mounjaro (tirzepatide), the first and only single molecule GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes is now available in Canada

2 November 2023 - Mounjaro represents the first new class of diabetes medicines introduced in nearly a decade and is now ...

Read more →

Fresh hope over discontinued painkiller but patients fear replacement doses are 'useless'

27 October 2023 - Patients with terminal illnesses and painful chronic conditions have been offered hope thanks to a deal ...

Read more →

Celltrion USA announces distribution and incorporation of Yuflyma (adalimumab-aaty), a Humira biosimilar, to CarePartners Specialty Pharmacy Cost Savings Programs

26 October 2023 - The treatment will be available on CarePartners Specialty Pharmacy Program in late October and will make ...

Read more →

Reforming pharmacy benefit managers - a review of bipartisan legislation

28 October 2023 - Policy makers are considering legislation that would address several well known problems with the pharmacy benefit management ...

Read more →

EMA takes further steps to address critical shortages of medicines in the EU

24 October 2023 - Today, the EMA published details of the newly created solidarity mechanism developed by the EMA Medicines Shortages ...

Read more →

Who profits most from America’s baffling health care system?

8 October 2023 - Hint: it isn’t big pharma. ...

Read more →

Cancer drug shortage eases slightly, but it’s still ‘living from paycheck to paycheck’

5 October 2023 - The shortage of cancer drugs is not going away, but it may be easing slightly, a ...

Read more →

New rules for weight loss ‘wonder drug’ after regulator clamp down

23 September 2023 - Australia’s pharmaceuticals regulator has ushered in new rules for a diabetes drug, which is being hailed by ...

Read more →

Supply and insurance issues snarl fall COVID-19 vaccine campaign for some

20 September 2023 - It has been just over a week since the US FDA and the US Centers for ...

Read more →

COVID-19 vaccine contract summary

18 September 2023 - The Ministry of Health has released a summary of the New Zealand Government’s procurement process for ...

Read more →

Treatment options for people with glioma, a type of brain cancer

13 September 2023 - BMS, the supplier of lomustine, a treatment used for a type of brain cancer called glioma, is ...

Read more →

Ozempic and Wegovy maker ‘just scratching the surface’ in meeting demand for weight loss drugs, CEO says

5 September 2023 - It could take years before Novo Nordisk has fulfilled demand for its highly popular weight loss ...

Read more →